ESMO: Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer
Newswise — MADRID ― Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery – significantly improved event-free survival (EFS) in patients with…
Read more ESMO: Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer